The global market for dexmethylphenidate, a potent medication used primarily for the treatment of attention deficit hyperactivity disorder (ADHD), is experiencing significant growth. This market expansion is driven by an increasing awareness of ADHD, rising diagnosis rates, and the need for effective therapeutic options. Dexmethylphenidate, marketed under brand names such as Focalin and Focalin...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian